Clinical trials
Recruiting Phase 1 trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
76 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 8 |
| 2022 | 6 |
| 2023 | 11 |
| 2024 | 21 |
| 2025 | 11 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 76 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Corporation | 5 |
| Eli Lilly and Company | 4 |
| Novartis Pharmaceuticals | 4 |
| Philogen S.p.A. | 4 |
| Bayer | 3 |
| GlaxoSmithKline | 3 |
| Bambino Gesù Hospital and Research Institute | 2 |
| Bristol-Myers Squibb | 2 |
| Cullinan Therapeutics Inc. | 2 |
| Genentech, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 13 |
| Colorectal Neoplasms | 9 |
| Neoplasms | 8 |
| Lymphoma, Follicular | 7 |
| Triple Negative Breast Neoplasms | 7 |
| Lymphoma, Large B-Cell, Diffuse | 6 |
| Breast Neoplasms | 5 |
| Lymphoma, Mantle-Cell | 5 |
| Lymphoma, Non-Hodgkin | 5 |
| Arthritis, Rheumatoid | 4 |
Trials
Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.